Literature DB >> 33714742

Mineralocorticoid Receptor Antagonists and SGLT2 Inhibitor Therapy: The Best of Both Worlds in HFrEF.

Faiez Zannad1, Patrick Rossignol2.   

Abstract

Entities:  

Keywords:  SGLT2 inhibitor; aldosterone; dapagliflozin; heart failure; hyperkalemia; kidney function; mineralocorticoid receptor antagonist; potassium

Year:  2021        PMID： 33714742     DOI： 10.1016/j.jchf.2020.12.009

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN： 2213-1779            Impact factor:   12.035


× No keyword cloud information.
  1 in total

1.  Egyptian Atherosclerosis and Vascular Biology Association Consensus on the Use of Sodium Glucose Cotransporter-2 Inhibitors in Heart Failure with Reduced Ejection Fraction.

Authors:  Ahmed S Elserafy; Ashraf Reda; Elsayed Farag; Tamer Mostafa; Nabil Farag; Atef Elbahry; Osama Sanad; Ahmed Bendary; Ahmed Elkersh; Ihab Attia; Mohammed Selim; Hazem Khamis; Emad R Issak
Journal:  Clin Drug Investig       Date:  2021-11-15       Impact factor: 2.859
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.